Search

Francois Maltais

from Stoneham, MA
Age ~58
Get Report
Connected to:
Bryan R Maltais, 47Denis Maltais, 82Glenn A Maltais, 62Laura K Maltais, 45Luc Maltais, 63Manon Maltais, 66Nicholas A Maltais, 59Ronald E Maltais, 70Ratko Maltar, 65Eric J Maltarich, 41

Francois Maltais Phones & Addresses

  • 52 Walsh Ave, Stoneham, MA 02180
  • 24 Randolph Dr, Tewksbury, MA 01876 (978) 851-0942
  • Cambridge, MA
  • Somerville, MA
  • 24 Randolph Dr, Tewksbury, MA 01876

Work

Position: Sales Occupations

Business Records

Name / Title
Company / Classification
Phones & Addresses
Francois Maltais
FM Logistics
Freight Traffic Services. Loading Dock Supply Companies. Cargo Freight Container Suppliers
7725 - 48 Street SE, Calgary, AB T2C 2V3
(403) 723-0779
Francois Maltais
Amalco Transport Inc.
Light Truck Haulers
7725 - 48 Street SE, Calgary, AB T2C 2V3
Francois Maltais
Amalco Transport Inc
Light Truck Haulers
Francois Maltais
FM Logistics
Freight Traffic Services · Loading Dock Supply Companies · Cargo Freight Container Suppliers
(403) 723-0779

Publications

Us Patents

Isoxazole Compositions Useful As Inhibitors Of Erk

View page
US Patent:
6495582, Dec 17, 2002
Filed:
Sep 14, 2001
Appl. No.:
09/953120
Inventors:
Michael Hale - Bedford MA
James Janetka - Beverly MA
Francois Maltais - Tewksbury MA
Jingrong Cao - West Newton MA
Robert Mashal - West Newton MA
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
C07D41304
US Classification:
514378, 548247
Abstract:
Described herein are compounds that are useful as protein kinase inhibitors, especially inhibitors of ERK, having the formula: where A, B, R , R , T and Ht are described in the specification. The compounds are useful for treating diseases in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.

Pyrazole Compositions Useful As Inhibitors Of Erk

View page
US Patent:
6528509, Mar 4, 2003
Filed:
Oct 5, 2001
Appl. No.:
09/972437
Inventors:
Michael Hale - Bedford MA
Xiaoling Xie - Cambridge MA
Jeremy Green - Burlington MA
Jingrong Cao - Newton MA
Christopher Baker - Bedford MA
Francois Maltais - Somerville MA
James Janetka - Beverly MA
Guy Bemis - Arlington MA
Michael Mullican - Needham MA
Judith Straub - Cambridge MA
Qing Tang - Cambridge MA
Robert Mashal - West Newton MA
Assignee:
Vertex Pharmacuticals, Incorporated - Cambridge MA
International Classification:
A61K 315377
US Classification:
5142365, 540575, 544140, 544295, 544328, 544367, 544371, 544363, 546 86, 546146, 546199, 5462737, 5462754, 546211, 548127, 5483124, 5483641, 5483644, 5483657
Abstract:
Described herein are compounds that are useful as protein kinase inhibitors having the formula: where R , Q, and T are described in the specification. The compounds are useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.

Pyrazole Compositions Useful As Inhibitors Of Erk

View page
US Patent:
6593357, Jul 15, 2003
Filed:
Aug 22, 2002
Appl. No.:
10/225719
Inventors:
Jeremy Green - Burlington MA
Jingrong Cao - Newton MA
Michael Hale - Bedford MA
Christopher Baker - Bedford MA
Francois Maltais - Somerville MA
James Janetka - Beverly MA
Michael Mullican - Needham MA
Guy Bemis - Arlington MA
Xiaoling Xie - Cambridge MA
Judith Straub - Cambridge MA
Qing Tang - Cambridge MA
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A61K 314155
US Classification:
514406, 544328, 5462754, 546211, 5483641, 5483644, 5483657, 548127, 5483117, 5483127
Abstract:
Described herein are compounds that are useful as protein kinase inhibitors having the formula: where R , Q, and T are described in the specification. The compounds are useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.

Isoxazole Compositions Useful As Inhibitors Of Erk

View page
US Patent:
6649640, Nov 18, 2003
Filed:
Oct 15, 2002
Appl. No.:
10/272622
Inventors:
Michael Hale - Bedford MA
James Janetka - Beverly MA
Francois Maltais - Somerville MA
Jingrong Cao - West Newton MA
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A61K 31422
US Classification:
514378, 548247
Abstract:
Described herein are compounds that are useful as protein kinase inhibitors, especially inhibitors of ERK, having the formula: where A, B, R , R , T and Ht are described in the specification. The compounds are useful for treating diseases in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.

Pyrazole Compositions Useful As Inhibitors Of Erk

View page
US Patent:
6699865, Mar 2, 2004
Filed:
Jan 2, 2003
Appl. No.:
10/335793
Inventors:
Michael Hale - Bedford MA
Xiaoling Xie - Cambridge MA
Jeremy Green - Burlington MA
Jingrong Cao - Newton MA
Christopher Baker - Bedford MA
Francois Maltais - Somerville MA
James Janetka - Beverly MA
Guy Bemis - Arlington MA
Michael Mullican - Needham MA
Judith Straub - Cambridge MA
Qing Tang - Cambridge MA
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A61K 314155
US Classification:
5142365, 540575, 544140, 544295, 544363, 544371, 546146, 546199, 546211, 546 86, 5483641
Abstract:
Described herein are compounds that are useful as protein kinase inhibitors having the formula: where R , Q, and T are described in the specification. The compounds are useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.

Heterocyclic Inhibitors Of Erk2 And Uses Thereof

View page
US Patent:
6743791, Jun 1, 2004
Filed:
Feb 8, 2002
Appl. No.:
10/071699
Inventors:
Jingrong Cao - Newton MA
Jeremy Green - Burlington MA
Michael Hale - Bedford MA
Francois Maltais - Tewksbury MA
Judy Straub - Cambridge MA
Qing Tang - Cambridge MA
Alex Aronov - Watertown MA
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
C07D40304
US Classification:
5142358, 51426622, 514275, 544122, 544284, 544331
Abstract:
Described herein are compounds that are useful as protein kinase inhibitors having the formula: wherein Z and Z are each independently nitrogen or CH and Ring A, T R , QR , U R , and Sp are as described in the specification. The compounds are especially useful as inhibitors of ERK2 and for treating diseases in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, diabetes, and cardiovascular disease.

Pyrazole-Derived Kinase Inhibitors And Uses Thereof

View page
US Patent:
6750239, Jun 15, 2004
Filed:
Aug 2, 2002
Appl. No.:
10/212294
Inventors:
Michael Robin Hale - Bedford MA
James Walter Janetka - Beverly MA
Francois Maltais - Tewksbury MA
Qing Tang - Cambridge MA
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A61K 314155
US Classification:
514406, 5483641
Abstract:
Described herein are compounds that are useful as protein kinase inhibitors having the formula: wherein B, R , n, R , Q and R are described in the specification. The compounds are useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.

Pyrazole Compositions Useful As Inhibitors Of Erk

View page
US Patent:
6784195, Aug 31, 2004
Filed:
Oct 5, 2001
Appl. No.:
09/971497
Inventors:
Michael Hale - Bedford MA
James Janetka - Beverly MA
Francois Maltais - Somerville MA
Jingrong Cao - Newton MA
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A61K 314196
US Classification:
514341, 514359, 514381, 514383, 514407, 5462724, 548253, 548255, 5482662, 5483654
Abstract:
Described herein are compounds that are useful as protein kinase inhibitors having the formula: where R , R , T and Ht are described in the specification. The compounds are useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.
Control profile
Francois Maltais from Stoneham, MA, age ~58 Get Report